Search research articles
Contact Us
Filters
Showing results (31-40 of 308) with videos related to
Page
of 31
Sort By:
Rheumatology (Oxford, England)
|
September 17, 2015
Towards prevention of autoantibody-positive rheumatoid arthritis: from lifestyle modification to preventive treatment
Danielle M Gerlag, Jill M Norris, Paul P Tak
Clinical Medicine (London, England)
|
December 5, 2015
Epigenetic mechanisms and drug discovery in rheumatology
David F Tough, Rab K Prinjha, Paul P Tak
Nature Reviews. Drug Discovery
|
December 30, 2016
Anti-colony-stimulating factor therapies for inflammatory and autoimmune diseases
John A Hamilton, Andrew D Cook, Paul P Tak
Arthritis and Rheumatism
|
March 4, 2008
Spondylarthritis in the absence of B lymphocytes
Dominique Baeten, Elli Kruithof, Maxime Breban, et al.
Arthritis Research & Therapy
|
March 17, 2015
Non-canonical NF-κB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde?
Ae R Noort, Paul P Tak, Sander W Tas
Expert Opinion on Emerging Drugs
|
June 7, 2005
Targeting cellular adhesion molecules, chemokines and chemokine receptors in rheumatoid arthritis
Jasper J Haringman, Roos L Oostendorp, Paul P Tak
Current Opinion in Rheumatology
|
April 11, 2012
Pathogenesis of spondyloarthritis: autoimmune or autoinflammatory?
Carmen Ambarus, Nataliya Yeremenko, Paul P Tak, et al.
Arthritis Research
|
November 28, 2002
Interferon-beta for treatment of rheumatoid arthritis?
Judith van Holten, Christine Plater-Zyberk, Paul P Tak
Nature Reviews. Rheumatology
|
October 7, 2010
'MRI-tis' in the early diagnosis of axial SpA: issues and limitations
Leen De Rycke, Mario Maas, Paul P Tak, et al.
Nature Reviews. Rheumatology
|
April 2, 2009
The cholinergic anti-inflammatory pathway: towards innovative treatment of rheumatoid arthritis
Marjolein A van Maanen, Margriet J Vervoordeldonk, Paul P Tak
Page
of 31
Search research articles
Search
Showing results (31-40 of 308) with videos related to
Sort By:
Page
of 31
Rheumatology (Oxford, England)
|
September 17, 2015
Towards prevention of autoantibody-positive rheumatoid arthritis: from lifestyle modification to preventive treatment
Danielle M Gerlag, Jill M Norris, Paul P Tak
Clinical Medicine (London, England)
|
December 5, 2015
Epigenetic mechanisms and drug discovery in rheumatology
David F Tough, Rab K Prinjha, Paul P Tak
Nature Reviews. Drug Discovery
|
December 30, 2016
Anti-colony-stimulating factor therapies for inflammatory and autoimmune diseases
John A Hamilton, Andrew D Cook, Paul P Tak
Arthritis and Rheumatism
|
March 4, 2008
Spondylarthritis in the absence of B lymphocytes
Dominique Baeten, Elli Kruithof, Maxime Breban, et al.
Arthritis Research & Therapy
|
March 17, 2015
Non-canonical NF-κB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde?
Ae R Noort, Paul P Tak, Sander W Tas
Expert Opinion on Emerging Drugs
|
June 7, 2005
Targeting cellular adhesion molecules, chemokines and chemokine receptors in rheumatoid arthritis
Jasper J Haringman, Roos L Oostendorp, Paul P Tak
Current Opinion in Rheumatology
|
April 11, 2012
Pathogenesis of spondyloarthritis: autoimmune or autoinflammatory?
Carmen Ambarus, Nataliya Yeremenko, Paul P Tak, et al.
Arthritis Research
|
November 28, 2002
Interferon-beta for treatment of rheumatoid arthritis?
Judith van Holten, Christine Plater-Zyberk, Paul P Tak
Nature Reviews. Rheumatology
|
October 7, 2010
'MRI-tis' in the early diagnosis of axial SpA: issues and limitations
Leen De Rycke, Mario Maas, Paul P Tak, et al.
Nature Reviews. Rheumatology
|
April 2, 2009
The cholinergic anti-inflammatory pathway: towards innovative treatment of rheumatoid arthritis
Marjolein A van Maanen, Margriet J Vervoordeldonk, Paul P Tak
Page
of 31